Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 5NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 24Lymphoid 15Myeloid 13Classical hematology 3Plasma cell 2Other neoplasm 1Other 1

Conditions

Precancerous Conditions 20Neoplasms 9Advanced Malignant Neoplasm 9Keratosis, Actinic 8Skin Diseases 5Keratosis 5Uterine Cervical Neoplasms 3Uterine Cervical Dysplasia 2Preleukemia 2Pathologic Processes 2Neoplasms by Site 2Neoplasms by Histologic Type 2Myelodysplastic Syndromes 2Leukemia, Myeloid, Acute 2Leukemia 2Hormone Receptor Positive Malignant Neoplasm of Breast 2Hematologic Diseases 2Endometrial Neoplasms 2Carcinoma 2Breast Neoplasms 2Bone Marrow Diseases 2Biochemical Recurrence of Malignant Neoplasm of Prostate 2Uterine Prolapse 1Uterine Neoplasms 1Uterine Diseases 1Uterine Cervical Diseases 1Urogenital Neoplasms 1Urogenital Diseases 1Thrombocythemia, Essential 1Syndrome 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Graft vs Host Disease × Other neoplasm × Clear all
NCT07216443 2026-04-15

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

Orca Biosystems, Inc.

Phase 2 Recruiting
80 enrolled
MyeloidOther hematologic neoplasmOther neoplasm

Acute Disease, Bone Marrow Diseases, Disease, Graft vs Host Disease, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Myelodysplastic Syndromes, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Precancerous Conditions, Preleukemia, Syndrome, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Disease Attributes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡